A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
Clinical trial NCT06006286 · WITHDRAWN
Trial details
- NCT number
- NCT06006286
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-08
- Primary completion
- 2023-11-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.